tert-Butyl (3-(hydroxymethyl)cyclobutyl)carbamate

Catalog No. :
ACCHGK897
CAS No. :
130369-05-0
Molecular Formula :
C10H19NO3
Molecular Weight :
201.27

IUPAC Name:tert-butyl (3-(hydroxymethyl)cyclobutyl)carbamate

tert-Butyl (3-(hydroxymethyl)cyclobutyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$147.00Login to see priceIn stockInquiry
10g97%$281.00Login to see priceIn stockInquiry
25g97%$561.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-(hydroxymethyl)cyclobutyl)carbamate
IUPAC Nametert-butyl (3-(hydroxymethyl)cyclobutyl)carbamate
MDL No.MFCD09864183
Molecular FormulaC10H19NO3
Molecular Weight201.27
SMILESO=C(OC(C)(C)C)NC1CC(CO)C1
InChI KeyPCPNTJQMXAHNOA-UHFFFAOYSA-N
Synonym3-(Boc-aMino)cyclobutaneMethanol;[3-(Hydroxymethyl)cyclobutyl]carbamic acid tert-butyl ester;3-(Boc-amino)cyclobutanemethanol - A11848;Carbamic acid, [3-(hydroxymethyl)cyclobutyl]-, 1,1-dimethylethyl ester (9CI);Carbamic acid, N-[3-(hydroxymethyl)cyclobutyl]-, 1,1-dimethylethyl ester;3-(Boc-amino)cyclobutyl]methanol
CAS No.130369-05-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACCHGK897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNSUQ083 route compound structure diagram
    ACNSUQ083130369-06-1 In Stock
  4. Then
  5. ACCHGK897 route product structure diagram
    ACCHGK897130369-05-0 In Stock
Inquiry

2. ACCHGK897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGZAF759 route compound structure diagram
    ACGZAF7591234616-81-9 In Stock
  2. Then
  3. ACCHGK897 route product structure diagram
    ACCHGK897130369-05-0 In Stock
Inquiry

Comments (0)